Hu Yang, Bakhotmah Balkees A, Alzahrani Owiss H, Wang Dong, Hu Frank B, Alzahrani Hasan A
Division of Rheumatology, Immunology and Allergy, Brigham & Women's Hospital, Boston, MA, United States.
The Mohammad Hussein Al Amoudi Chair for Diabetic Foot Research, Jeddah, Saudi Arabia; Department of Nutrition and Food Sciences, Jeddah, Saudi Arabia.
Diabetes Res Clin Pract. 2014 Nov;106(2):286-94. doi: 10.1016/j.diabres.2014.07.016. Epub 2014 Aug 7.
To identify risk factors and clinical biomarkers of prevalent diabetes foot complications, including foot ulcers, gangrene and amputations among patients with diabetes in Jeddah, Saudi Arabia.
598 diabetes patients from Jeddah participated in the current study. Patients were considered to have diabetes foot complications if they reported diagnosis of foot ulcers or gangrene or amputations in a questionnaire administered by a physician and confirmed by clinical exams. Information on socio-demographic and lifestyle variables was self-reported by patients, and several clinical markers were assessed following standard procedures.
The prevalence of diabetes foot complications in this population was 11.4%. In the multivariable model without adjustment for PAD (peripheral artery disease) and DPN (diabetes peripheral neuropathy), non-Saudi nationality, longer diabetes duration and insulin use was significantly associated with higher diabetes foot complications prevalence. Each 1g/L increase of hemoglobin was associated with 2.8% lower prevalence of diabetes foot complications. In the multivariable model adjusting for PAD and DPN, the previously observed associations except for nationality were no longer significant. Patients with both DPN and PAD had 9.73 times the odds of diabetes foot complications compared to the patients with neither condition.
In this population, longer diabetes duration, insulin use, lower hemoglobin levels and non-Saudi nationality were associated with higher prevalence of foot complications. These associations were largely explained by the presence of DPN and PAD except for non-Saudi nationality. Diabetes patients with both DPN and PAD had nearly 10-fold increased risk of foot complications than those with neither condition.
确定沙特阿拉伯吉达市糖尿病患者中常见糖尿病足并发症(包括足部溃疡、坏疽和截肢)的风险因素及临床生物标志物。
598名来自吉达市的糖尿病患者参与了本研究。若患者在医生进行的问卷调查中报告有足部溃疡、坏疽或截肢诊断且经临床检查确认,则被视为患有糖尿病足并发症。社会人口统计学和生活方式变量信息由患者自行报告,若干临床指标按照标准程序进行评估。
该人群中糖尿病足并发症的患病率为11.4%。在未对外周动脉疾病(PAD)和糖尿病周围神经病变(DPN)进行校正的多变量模型中,非沙特国籍、糖尿病病程较长和使用胰岛素与糖尿病足并发症患病率较高显著相关。血红蛋白每增加1g/L,糖尿病足并发症患病率降低2.8%。在对PAD和DPN进行校正的多变量模型中,除国籍外,先前观察到的关联不再显著。与既无DPN也无PAD的患者相比,同时患有DPN和PAD的患者发生糖尿病足并发症的几率高出9.73倍。
在该人群中,糖尿病病程较长、使用胰岛素、血红蛋白水平较低以及非沙特国籍与足部并发症患病率较高相关。除非沙特国籍外,这些关联在很大程度上可由DPN和PAD的存在来解释。同时患有DPN和PAD的糖尿病患者发生足部并发症的风险比既无DPN也无PAD的患者高出近10倍。